Download Citation
Article Source:
Feasibility of the Xemio app for breast cancer survivors in a clinical setting: Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL)
Fuentes-Expósito MA,
Frid S,
Muñoz-Mateu M,
Sisó-Almirall A,
Armayones Ruiz M,
et al.
(2026)
Feasibility of the Xemio app for breast cancer survivors in a clinical setting: Adherence, acceptance, and side effect monitoring (CTCAE vs. QoL).
PLOS ONE 21(5): e0342702.
https://doi.org/10.1371/journal.pone.0342702